Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARQ 501 in recurrent or metastatic leiomyosarcoma
NCT00310518Phase 2Completed
- Start
- Feb 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapachone in leiomyosarcoma (LMS). Started Feb 2006; status: completed.
02
Drugs
lapachone
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT00310518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310518.